tykhr
sign in
free sign up
Aslan Pharmaceuticals Ltd ADR
Biotechnology
Healthcare
ASLN
16.44 M shares
NASDAQ US
traded
18 Oct 2023
listed
yes
open
1.32
52 week high
4.59
high
1.35
52 week low
1.33
low
1.29
growth
-55.00 %
previous Close
1.43
P/E ratio
market cap
34.49 M
div yield
0
usd
Jun 2023
qoq
revenue
12.00 M
0.00 %
net incoming
-1.89 M
90.13 %
eps
0.00 %
91.47 %
eps surprise
86.25 %
net profit margin
-15.71 %
-15.00 %
operating incoming
-2.36 M
86.94 %
net change in cash
0.00 %
cash on hand
40.94 M
-28.79 %
cost of revenue
0.00 %
top